A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly Participants
Clinical trial NCT05745207 · COMPLETED
Trial details
- NCT number
- NCT05745207
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-20
- Primary completion
- 2024-01-18
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.